# A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel

> **NCT01844739** · PHASE1 · COMPLETED · sponsor: **Novan, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** NVN1000 4% Gel
- **DRUG:** Vehicle Gel

## Key facts

- **NCT ID:** NCT01844739
- **Lead sponsor:** Novan, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01844739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01844739, "A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel". Retrieved via AI Analytics 2026-09-20 from https://api.ai-analytics.org/clinical/NCT01844739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*